Results 71 to 80 of about 7,736 (213)

TAVR vs SAVR: rising expectations and changing indications for surgery in response to PARTNER II

open access: yes, 2017
Despite the criticisms and concerns raised on the data published in the PARTNER II trial and related analyses, we are undeniably witnessing a revolution in the management of aortic valve disease, in which conventional full sternotomy surgical aortic ...
Nappi, Francesco   +7 more
core   +1 more source

Image_6_Trend and Impact of Concomitant CABG and Multiple-Valve Procedure on In-hospital Outcomes of SAVR Patients.TIF

open access: yes, 2021
Background: The trends of concomitant CABG and multiple-valve procedures and their impact on in-hospital outcomes in the context of transcatheter aortic valve replacement are unexplored.Methods: This was a retrospective cohort study using the ...
Xiaoqiang Cong (9737075)   +3 more
core   +1 more source

Heart failure hospitalization following surgical or transcatheter aortic valve implantation in low‐risk aortic stenosis

open access: yesESC Heart Failure
Aims In low‐risk patients with severe aortic stenosis (AS), sutureless surgical aortic valve replacement (SU‐SAVR) may be an alternative to transcatheter aortic valve implantation (TAVI). The risk of heart failure hospitalization (HFH) after aortic valve
Helena Lopez‐Martinez   +15 more
doaj   +1 more source

Coronary revascularization after surgical aortic valve replacementCentral MessagePerspective

open access: yesJTCVS Open, 2020
Objective: It remains unclear how often coronary revascularization is necessary after aortic valve interventions, either by surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement. However, these data are relevant for treatment
Mevlüt Çelik, BSc   +7 more
doaj   +1 more source

TAVR or SAVR: Unfinished Business [PDF]

open access: yesInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2021
openaire   +2 more sources

TAVR as an Alternative to SAVR for Pure Native Aortic Regurgitation

open access: yesCanadian Journal of Cardiology
Although transcatheter aortic valve replacement was originally fulfilling an unmet clinical need in the elderly population suffering from tricuspid aortic valve stenosis, its use has been progressively expanded to other groups of patients. In this review, we focus on pure native aortic valve regurgitation, which is in most cases a degenerative disease ...
Noble, Stéphane Laurent   +1 more
openaire   +3 more sources

Pacing Ratio Changes of an Implanted Permanent Pacemaker After Transcatheter Aortic Valve Implantation

open access: yesPacing and Clinical Electrophysiology, Volume 49, Issue 6, Page 768-777, June 2026.
ABSTRACT Background In some patients, transcatheter aortic valve implantation (TAVI) is associated with conduction disturbances, necessitating permanent pacemaker implantation (PMI). The clinical course of conduction disturbances after PMI, based on the type of TAVI valve, remains unclear.
Yu Fukuoka   +10 more
wiley   +1 more source

Association of TAVI vs SAVR with a composite of all-cause mortality and disabling stroke, stratified by surgical risk.

open access: yes, 2019
TAVI = Transcatheter aortic valve implantation, SAVR = surgical aortic valve replacement, M-H = Mantel-Haenszel.
Yaqin Zhao (7067738)   +5 more
core   +1 more source

Table_3_Trend and Impact of Concomitant CABG and Multiple-Valve Procedure on In-hospital Outcomes of SAVR Patients.DOCX

open access: yes, 2021
Background: The trends of concomitant CABG and multiple-valve procedures and their impact on in-hospital outcomes in the context of transcatheter aortic valve replacement are unexplored.Methods: This was a retrospective cohort study using the ...
Xiaoqiang Cong (9737075)   +3 more
core   +1 more source

Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation

open access: yesHealth Technology Assessment, 2013
Background: Calcific aortic stenosis (AS) is a common valvular heart disease. Patients with severe symptomatic AS typically survive less than 3 years.
R Orlando   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy